BAX

#818
Baxter International Inc. Common Stock
18.8 0 USD
-2.29%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
18.77
19.01
Intervallo Annuale
15.73
32.04
Variazione giornaliera
-2.29%
Variazione Mensile
+6.03%
Variazione di 6 mesi
+1.35%
Variazione Annuale
-38.18%
Chiusura Precedente
19.2 4
Open
18.8 8
Minimo
18.7 7
High
19.0 1
Volume
2 194
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche Dividendi
Trimestrale Annuale
  • Market Capitalization 9.71 B
  • Employee 38 K
  • Founded N/A
  • CEO Andrew Hider
  • Website www.baxter.com
  • Headquarter Delaware, United States
  • FIGI BBG000BCVJ77
  • Industry Strumenti e Forniture Mediche
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-7.81
Rapporto prezzo/fatturato
0.76
Dividendi per azione
0.01
Rendimento da dividendi %
5.18

Baxter International Inc. Common Stock

Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals. Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients. Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services". Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology.

Notizie